IDL Diagnostics AB (publ) (STO:IDLDX)

Sweden · Delayed Price · Currency is SEK

0.2860

+0.0020 (0.70%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Bacteriology	29.58M	-	-	-	-
Other Segments	76.00K	-	-	-	-
Oncology	23.46M	-	-	-	-
Biotechnology	-	57.44M	43.04M	36.99M	12.00M
Biotechnology Growth	-	33.45%	16.37%	208.32%	14180.95%
Total	53.11M	57.44M	43.04M	36.99M	12.00M
Total Growth	-7.53%	33.45%	16.37%	208.32%	14180.95%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe	23.21M	-	-	-	-
Asia	29.48M	-	-	-	-
Americas	139.00K	-	-	-	-
Mea	171.00K	-	-	-	-
Africa	113.00K	-	-	-	-
Sweden	-	57.44M	43.04M	36.99M	12.00M
Sweden Growth	-	33.45%	16.37%	208.32%	14180.95%
Total	53.11M	57.44M	43.04M	36.99M	12.00M
Total Growth	-7.54%	33.45%	16.37%	208.32%	14180.95%

Source: S&P Global Market Intelligence.